Bala Vanessa Meletia

Bala Vanessa Meletia Internist Oncologist

Consultant at 2nd Department of Medical Oncology, MITERA HOSPITAL

Education & Academic Qualifications

  • Medical License Medical School, University of Athens, Greece 2013
  • Specialty in Medical Oncology 2022, Greece
  • PhD Candidate Medical School, University of Athens, Greece 2022
  • MSc on Neoplastic disease in Human: Diagnosis, treatment and research, Faculty of Medicine, National & Kapodistrian University of Athens, Greece, 2019
  • Diploma of the Hellenic Boards of Oncology Hellenic Society of Medical Oncology 2023

Board Member

Member of ESMO, Hellenic Society of Medical Oncology (HESMO) and the Hellenic Cooperative Oncology Group (HeCOG)

Professional Experience

· 03.2023 – today Medical Oncologist YGEIA & MITERA Hospital

· 12.2022 – 03.2023 Medical Oncologist, Euroclinic, Athens, Greece

· 02.2020 – 12.2022 Resident Doctor in Medical Oncology, 2nd Department of Medical Oncology, General Oncologica11Hospital of Kifissia

· 11.2018 – 02.2020 Resident Doctor, Oncology Department, General Hospital of Athens “G.Gennimatas”

· 11.2017-11.2018 Resident Doctor in Hematology, General Hospital of Athens “G.Gennimatas”

· 11.2013-11.2015 Resident Doctor in Internal Medicine, 1st Department of Internal Medicine, General Hospital of Athens “G.Gennimatas”

· Resident doctor in Medical Oncology, Department of Oncology and Cellular Therapy, Hôpital Tenon AP-HP, Paris, 05.2015-11.2015 and Pneumonology and Oncology Department, Centre Hospitalier Saint Germain En Laye, Paris, France, 11.2013 – 05.2013

· 05.2014 – 05.2015 Resident doctor in Internal Medicine, Department of Internal Medicine, Centre Hospitalier Saint Germain En Laye, Paris, France and Department of Internal Medicine, Centre Hospitalier d’Orsay, Paris, France

· 02.2013 – 10.2013 Research Assistant, Oncology Unit, General Hospital of Athens Ippokrateio

Education Experience

· Presentations at numerous congresses

· Active member of the General Medicine training program of the Université de Versailles, with responsibility for coordinating and conducting speeches and councils.





Clinical and Research Interest

· Gynaecological cancer

· Urogenital cancer

· Gastrointestinal cancer

· Immuno-oncology

Recent Publications

•  An overview of hormonal directed pharmacotherapy for the treatment of prostate cancer, Expert Opinion on Pharmacotherapy, 24:16, 1765-1774, DOI: 10.1080/14656566.2023.2244415 Maria Mitsogianni, Athanasios Papatsoris, Vanessa-Meletia Bala, Hussein Issa, Mohammad Moussa & Iraklis Mitsogiannis (2023)

• The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection. The Journal of Infection in Developing Countries 2022-01-31 | Journal article DOI: 10.3855/jidc.15386 Dimitra Ioanna Lampropoulou; Vanessa Meletia Bala; Eleni Zerva; Evangelia Pliakou; Dimitrios Filippou; Maria Gazouli; Gerasimos Aravantinos

• Mediastinal and hilar sarcoid-like reaction in a patient treated with dabrafenib and trametinib for metastatic melanoma: A case report and review of the literature. Mol Clin Oncol. 2022 May;16(5):99. doi: 10.3892/mco.2022.2532. Bala VM, Mitsogianni M, Laschos K, Pliakou E, Lazaridi E, Lampropoulou DI, Aravantinos G.